4.7 Article

Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy

期刊

SCIENTIFIC REPORTS
卷 6, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/srep20193

关键词

-

资金

  1. National Institutes of Health [NS055925, NS080294]
  2. Salsbury Endowment
  3. Iowa Center for Advanced Neurotoxicology (Iowa State University, IA, USA)

向作者/读者索取更多资源

A Spinal muscular atrophy (SMA) is caused by low levels of survival motor neuron (SMN), a multifunctional protein essential for higher eukaryotes. While SMN is one of the most scrutinized proteins associated with neurodegeneration, its gender-specific role in vertebrates remains unknown. We utilized a mild SMA model (C/C model) to examine the impact of low SMN on growth and development of mammalian sex organs. We show impaired testis development, degenerated seminiferous tubules, reduced sperm count and low fertility in C/C males, but no overt sex organ phenotype in C/C females. Underscoring an increased requirement for SMN expression, wild type testis showed extremely high levels of SMN protein compared to other tissues. Our results revealed severe perturbations in pathways critical to C/C male reproductive organ development and function, including steroid biosynthesis, apoptosis, and spermatogenesis. Consistent with enhanced apoptosis in seminiferous tubules of C/C testes, we recorded a drastic increase in cells with DNA fragmentation. SMN was expressed at high levels in adult C/C testis due to an adult-specific splicing switch, but could not compensate for low levels during early testicular development. Our findings uncover novel hallmarks of SMA disease progression and link SMN to general male infertility.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy

N. N. Singh, M. D. Howell, E. J. Androphy, R. N. Singh

GENE THERAPY (2017)

Article Biochemistry & Molecular Biology

High-affinity RNA targets of the Survival Motor Neuron protein reveal diverse preferences for sequence and structural motifs

Eric W. Ottesen, Natalia N. Singh, Diou Luo, Ravindra N. Singh

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemistry & Molecular Biology

Human Survival Motor Neuron genes generate a vast repertoire of circular RNAs

Eric W. Ottesen, Diou Luo, Joonbae Seo, Natalia N. Singh, Ravindra N. Singh

NUCLEIC ACIDS RESEARCH (2019)

Review Biochemistry & Molecular Biology

A novel role of U1 snRNP: Splice site selection from a distance

Ravindra N. Singh, Natalia N. Singh

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)

Article Biochemistry & Molecular Biology

How RNA structure dictates the usage of a critical exon of spinal muscular atrophy gene

Natalia N. Singh, Ravindra N. Singh

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)

Editorial Material Biochemistry & Molecular Biology

RNA structure and splicing regulation

Francisco E. Baralle, Ravindra N. Singh, Stefan Stamm

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)

Editorial Material Chemistry, Medicinal

More is needed to complement the available therapies of spinal muscular atrophy

Ravindra N. Singh

FUTURE MEDICINAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

A survey of transcripts generated by spinal muscular atrophy genes

Natalia N. Singh, Eric W. Ottesen, Ravindra N. Singh

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2020)

Review Pharmacology & Pharmacy

RNA in spinal muscular atrophy: therapeutic implications of targeting

Ravindra N. Singh, Joonbae Seo, Natalia N. Singh

EXPERT OPINION ON THERAPEUTIC TARGETS (2020)

Review Cell Biology

Characteristics of circular RNAs generated by human Survival Motor Neuron genes

Eric W. Ottesen, Ravindra N. Singh

CELLULAR SIGNALLING (2020)

Article Biochemistry & Molecular Biology

Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes

Natalia N. Singh, Shaine Hoffman, Prabhakara P. Reddi, Ravindra N. Singh

Summary: Spinal muscular atrophy (SMA) is a major genetic disorder associated with infant mortality, primarily caused by deletions or mutations in the Survival Motor Neuron 1 (SMN1) gene. The spectrum of SMA ranges from prenatal death to survival into adulthood, with all tissues potentially affected.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Biochemistry & Molecular Biology

High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome

Eric William Ottesen, Diou Luo, Natalia Nikolaevna Singh, Ravindra Narayan Singh

Summary: The intronic splicing silencer N1 (ISS-N1) within Survival Motor Neuron 2 (SMN2) intron 7 is a therapeutic target for treating spinal muscular atrophy. Treatment with 100 nM of Anti-N1 resulted in substantial stimulation of SMN2 exon 7 inclusion but also caused significant perturbations in the transcriptome and widespread aberrant splicing. Shorter ISS-N1-targeting ASOs showed a substantial reduction in off-target effects, providing important insights for better ASO design and dosing regimens of ASO-based drugs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Genetics & Heredity

Internal Introns Promote Backsplicing to Generate Circular RNAs from Spinal Muscular Atrophy Gene

Diou Luo, Natalia Nikolaevna Singh, Ravindra Narayan Singh

Summary: This study investigates the generation mechanism of circRNA in SMN genes. It finds that the presence of introns enhances the rate of circRNA generation and that the exon junction complex plays a role in the generation of circRNAs containing only exons. In addition, SMN circRNAs are preferentially localized in the cytoplasm.
Article Biochemistry & Molecular Biology

Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy

Eric W. Ottesen, Natalia N. Singh, Diou Luo, Bailey Kaas, Benjamin J. Gillette, Joonbae Seo, Hannah J. Jorgensen, Ravindra N. Singh

Summary: Designing an RNA-interacting molecule that exhibits both high therapeutic efficacy and concentration-specific specificity remains challenging. Risdiplam and branaplam, two small molecules approved for the treatment of spinal muscular atrophy (SMA) and undergoing clinical trials, respectively, are able to restore the inclusion of Survival Motor Neuron 2 (SMN2) exon 7. However, the transcriptome-wide off-target effects of these compounds in SMA patient cells reveal concentration-dependent changes and perturbations in gene expression, splicing events, and cellular pathways. Understanding these off-target effects and their mechanisms can guide the development of improved dosing regimens and future small molecule therapeutics for splicing modulation.

NUCLEIC ACIDS RESEARCH (2023)

Review Neurosciences

The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy

Ravindra N. Singh, Eric W. Ottesen, Natalia N. Singh

NEUROSCIENCE INSIGHTS (2020)

暂无数据